| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Bradway Robert A | Chairman, CEO and President, Director | ONE AMGEN CENTER DRIVE, THOUSAND OAKS | /s/ Andrea A. Robinson, Attorney-in-Fact for Mr. Bradway | 05 May 2025 | 0001396482 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMGN | Common Stock | Tax liability | $704,058 | -2,481 | -0.61% | $283.78 | 402,540 | 02 May 2025 | Direct | |
| transaction | AMGN | Common Stock | Tax liability | $667,451 | -2,352 | -0.58% | $283.78 | 400,188 | 02 May 2025 | Direct | F1 |
| holding | AMGN | Common Stock | 90,000 | 02 May 2025 | By GRAT | ||||||
| holding | AMGN | Common Stock | 90,000 | 02 May 2025 | By Spousal GRAT |
| Id | Content |
|---|---|
| F1 | These shares include 1,424 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |